Open AccessThe utility of inhibitory quotients in determining the relative potency of protease inhibitors
Author(s) -
Peter J. Piliero
Publication year - 2002
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/00002030-200203290-00020
Subject(s) - potency , cmin , pharmacology , ec50 , integrase inhibitor , protease , drug , plasma protein binding , pharmacokinetics , darunavir , protease inhibitor (pharmacology) , in vivo , albumin , viremia , biology , glycoprotein , amprenavir , blood proteins , biochemistry , in vitro , immunology , hiv 1 protease , viral load , human immunodeficiency virus (hiv) , cmax , enzyme , antiretroviral therapy , microbiology and biotechnology